Phase-1 trial of Ebola vaccine gets underway in Uganda

Researchers in Masaka, Uganda, have begun a phase I trial of an experimental vaccine targeting the Bundibugyo strain of Ebola. There is currently no approved vaccine or effective treatment for this strain. The early-stage study is a step toward addressing that gap and highlights Uganda’s role in research aimed at improving health protection in Africa.

Summary written by SeeCave. The full story belongs to the original publisher.